Searchable abstracts of presentations at key conferences in endocrinology

ea0011p349 | Diabetes, metabolism and cardiovascular | ECE2006

Physiological concentrations of testosterone inhibit extracellular calcium entry via voltage-gated calcium channels in the A7r5 vascular smooth muscle cell line - a non-genomic effect

Hall J , Jones RD , Channer KS , Peers C , Jones TH

Testosterone (T) acts as a coronary vasodilator and reduces myocardial ischemia in men with coronary heart disease. We have previously demonstrated that T inhibits the pore forming alpha1c subunit of the cardiovascular L-type calcium channel in HEK293 cells. In this study we investigated the effects of T and 5β-dihydrotestosterone (5β-DHT) on extracellular calcium entry in A7r5 vascular smooth muscle cells (VSMCs). A7r5 cells grown on coverslips in 12-well plates in ...

ea0003p77 | Cytokines and Growth Factors | BES2002

Inhibitory effects of interleukin1-alpha, interleukin-6 and leptin on growth of HP75 human pituitary tumour cells

Hall J , Borg S , Kerry K , Jones T

Leptin is known to be produced by human pituitary adenomas, and inhibits the proliferation of HP75 cells in vitro. The HP75 cell line is derived from gonadotroph tumour cells from a clinically non-functioning human pituitary adenoma transfected with SV40. The aim of this study was to examine the effects of interleukins (IL) IL1-alpha and IL-6 on growth of HP75 cells and their effects on the growth inhibitory actions of leptin.HP75 cells were plated in 2...

ea0003p248 | Steroids | BES2002

The relationship between smoking, statin therapy and testosterone in men with coronary artery disease

Morris P , Pugh P , Hall J , Channer K , Jones T

BACKGROUND: We have previously shown that men with coronary artery disease (CAD) have lower serum bioavailable testosterone levels than men with normal coronary arteries and this may have detrimental effects in coronary disease. It has been suggested that low androgen levels in men with CAD could be accounted for by the high prevalence of statin therapy and other factors such as smoking. We investigated the effects of statin therapy and smoking on testosterone in men with CAD....

ea0003p251 | Steroids | BES2002

Testosterone therapy improves depressive symptoms in men with chronic heart failure

Pugh P , Jones R , Hall J , Channer K , Jones T

Objectives: Testosterone deficiency has been associated with depressive symptoms, which may be improved by replacement therapy. Patients with chronic heart failure have a high prevalence of depression, which is associated with early mortality in these patients. Men with heart failure may also have low plasma levels of testosterone, which could contribute to depressed mood. In a clinical study investigating whether testosterone treatment benefits men with heart failure, patient...

ea0009p26 | Diabetes and metabolism | BES2005

Physiological concentrations of testosterone inhibit extracellular calcium entry via voltage-gated calcium channels in the A7r5 vascular smooth muscle cell line

Hall J , Jones R , Kang P , Channer K , Peers C , Jones T

Testosterone is a coronary vasodilator and is known to increase ischaemic threshold in men with angina. We have previously demonstrated that testosterone inhibits the pore forming alpha1c subunit of the cardiovascular L-type calcium channel transfected into HEK293 cells. In this study we have investigated the effect of testosterone on potassium-stimulated extracellular calcium entry in A7r5 vascular smooth muscle cells (VSMCs).A7r5 cells grown...

ea0007p62 | Diabetes, metabolism and cardiovascular | BES2004

Physiological concentrations of testosterone inhibit extracellular calcium entry via voltage-gated calcium channels in A7r5 vascular smooth muscle cells

Hall J , Jones R , Kang P , Channer K , Peers C , Jones T

Testosterone therapy has been shown to be beneficial in men with coronary artery disease (CAD) and chronic heart failure (CHF), effects which are proposed to be due to a direct vasodilatory action. We utilised fluorescence measurements to investigate whether testosterone inhibits extracellular calcium entry induced by 50mM high potassium (K+) buffer, in A7r5 vascular smooth muscle cells.A7r5 cells were grown on coverslips in 12-well plates in ...

ea0005p225 | Steroids | BES2003

High prevalence of low testosterone levels in men with coronary heart disease and an association with hypertension and obesity - The South Yorkshire study

Pugh P , Morris P , Hall J , Malkin C , Asif S , Jones R , Channer K , Jones T

We(1) and others have established that men with coronary heart disease (CHD) have lower serum testosterone levels than men with normal coronaries. Hypotestosteronaemia is associated with dyslipidaemia, visceral obesity, insulin resistance, hypertension and a prothrombotic state.The aim of this study was to determine the prevalence of hypogonadism in men with CHD proven by either greater than 70 per cent stenosis of one or more epicardial or greater than 50 per cent stenosi...

ea0003p76 | Cytokines and Growth Factors | BES2002

Expression of the membrane interleukin-6 receptor (mIL6R) but absence of shedding of soluble IL6R (sIL6R) in human pituitary tumour cells

Borg S , Kerry K , Hall J , Suliman M , Royds J , Jones T

The cytokine IL-6 is synthesed and released by over half of surgically removed human pituitary adenomas and by the HP75 human pituitary tumour cell line. We have previously shown that IL6 is associated with tumour invasiveness but not with Ki67, a marker of cell proliferation. Membrane IL6R (mIL6R) has been demonstrated in some pituitary adenomas, however, we have shown that sIL6R is not shed by the majority (92%) of human pituitary adenomas in culture nor by HP75 cells(super)...

ea0003p250 | Steroids | BES2002

Testosterone and pro-inflammatory cytokines in men with chronic heart failure

Hall J , Pugh P , Jones R , Corlett G , Channer K , Jones T

Objectives: Pro-inflammatory cytokine levels are elevated in heart failure and have been implicated in disease progression. Testosterone has been shown to have anti-inflammatory properties and plasma levels may be reduced in men with heart failure. We studied the relation of endogenous testosterone with plasma cytokines in men with chronic heart failure and the effects of testosterone administration.Methods: Baseline plasma levels of total and bio-avail...

ea0003p253 | Steroids | BES2002

Testosterone and skeletal muscle parameters in men with chronic heart failure

Pugh P , Jones R , Hall J , Channer K , Jones T , van Beek E

Objectives: Patients with chronic heart failure (CHF) almost universally complain of exercise intolerance due, in part, to alterations of skeletal muscle. In men, testosterone is an important determinant of muscle bulk and strength. Relative androgen deficiency in men with CHF could contribute to exercise intolerance. We studied the relationship between plasma levels of testosterone and measures of skeletal muscle bulk and strength and exercise capacity in men with CHF.<p ...